The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes
Abstract The COVID-19 pandemic has affected more than 100 million cases and caused immense burdens on governments and healthcare systems worldwide. Since its emergence in December 2019, research has been focused on treating the infected, identifying those at risk and preventing spread. There is curr...
Guardado en:
Autores principales: | Marwa Ali Almadhi, Abdulkarim Abdulrahman, Abdulla Alawadhi, Ali A. Rabaan, Stephen Atkin, Manaf AlQahtani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/439f1272d58c4e9eb2562905cbe49056 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?
por: Nitya Kumar, et al.
Publicado: (2021) -
EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C
por: Fatma Burçin KURTİPEK, et al.
Publicado: (2021) -
ABO blood groups among Coronavirus disease 2019 patients
por: Tasneem A. Alkout, et al.
Publicado: (2020) -
ABO and Rhesus Blood Groups in Acute Puumala Hantavirus Infection
por: Johanna Tietäväinen, et al.
Publicado: (2021) -
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
por: Manaf AlQahtani, et al.
Publicado: (2021)